Occam Systems Inc. is a privately held technology and supply chain intelligence company founded by James Ferri (CEO and Co-Founder), a chemical engineer with three decades of experience in chemical process and product development. The company positions itself as the first chemical strategic supply chain operating system — a platform designed to make chemical input sourcing proactive, resilient, and data-driven rather than reactive and broker-dependent.

The company’s origin is explicitly rooted in pharmaceutical and defence supply chain security. Its founding technology was developed by synthesising university-led chemical research with enterprise-scale process development, and attracted early backing from DARPA (Defense Advanced Research Projects Agency), which sponsored a seedling project to design an optimised supply chain architecture for critical medicine manufacturing. ARPA-H (Advanced Research Projects Agency for Health) subsequently provided further funding to advance automation within virtual chemical process development. The company has since attracted both public and private investment to support commercial scale-up.

Occam’s stated focus is the $5 trillion global chemical supply chain, a market it characterizes as still operating on pre-internet infrastructure: brokers, phone calls, PDFs, and outdated spreadsheets. The company’s platform is built on the premise that 96% of everything manufactured on Earth begins with a chemical input, and that competitive advantage now belongs to the entities that source proactively, with the intelligence, resilience, and cost-efficiency to turn a historically opaque, broker-marked-up procurement process into a measurable driver of COGS reduction.

Occam’s commercial leadership is provided by Will Crimmins (SVP, Revenue), who brings 18 years of commercial leadership experience in specialty chemicals. No founding date or headquarters city is publicly disclosed on the website, though all indicators point to a US-based organisation with DARPA and ARPA-H funding relationships.

Key Products and Services

Dynamic Sourcing

• On-demand chemical input sourcing service for clients requiring specific chemical materials on specification, on time, and at competitive cost
• Supported by the underlying operating system’s intelligence layer, providing qualified alternate sources, real-time market awareness, and rapid pivot capability when primary sources are disrupted
• Accessible to organisations of any scale — from emerging companies to large pharmaceutical manufacturers — enabling access to sourcing intelligence and supplier command previously available only to large procurement organisations
• Delivers input-cost savings by surfacing competitive alternate sources and removing broker markup, directly reducing COGS for clients.

Supply Chain Design

• End-to-end supply chain design service for R&D and supply chain teams advancing target molecules towards commercial manufacturing
• Covers the full journey from molecule-on-the-bench to a qualified, sourced, and resilient commercial supply chain
• Delivered as a collaborative engagement, with Occam acting as an embedded supply chain design partner rather than a transactional broker

Enterprise Planning

• Integrated software platform deployment for large-scale pharmaceutical manufacturers, industrial companies, and government clients with complex, dynamic supply chain requirements
• Encompasses strategic planning, supply chain risk management, and decision-making under a single platform with a unified intelligence layer
• Customised to client operational footprint and built for continuous, real-time supply chain oversight rather than periodic review

Underlying Platform Capabilities

• AI-enabled chemical sourcing intelligence covering qualified primary and alternate sources for chemical inputs
• Resilience architecture ensuring every material carries a qualified alternate, with rapid re-routing and requalification when disruptions occur
• Agile pivot capability enabling response to supply disruptions in days rather than quarters
• Virtual chemical process development automation, advanced through ARPA-H collaboration

Occam Systems occupies a strategically significant and timely position at the intersection of pharmaceutical supply chain security, chemical sourcing intelligence, and AI-enabled enterprise software. Its origin in a DARPA-funded mandate to secure critical medicine supply chains gives it a credibility and validation pathway that few venture-backed supply chain technology companies possess, and the subsequent ARPA-H backing signals explicit US government recognition of the vulnerability of pharmaceutical raw material supply chains — a concern that has been highly visible since the COVID-19 pandemic exposed the risks of geographic concentration in API and chemical input production. The company’s platform targets a real and well-documented gap: the pharmaceutical industry’s reliance on opaque, relationship-dependent, broker-mediated chemical procurement processes that are poorly equipped to respond to geopolitical disruptions, regulatory changes, or supply shocks. For pharmaceutical manufacturers, particularly those dependent on API precursors and chemical intermediates sourced from concentrated geographies, Occam’s operating system offers a structural upgrade to sourcing capability, one that pairs commercial resilience with a direct, measurable impact on input costs, that is increasingly relevant to both margin performance and regulatory expectations around supply chain risk management.